Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Video Interview: BC Platforms Making Genomic Data Meaningful

This article was originally published in Scrip

Executive Summary

BC Platforms CEO Tero Silvola explains to Mike Ward, global director of content for Informa's pharma insights portfolio, how his company is working to solve the challenge pharma and biotech firms face managing and analyzing complex big data in a systematic, standardized and secure manner to improve R&D productivity, clinical decision making and patient outcomes. Founded in 1997, the Switzerland-based biocomputing company has developed technology that can integrate proprietary and public genomic data with wellbeing and healthcare data. The company already has more than 200 clients from academia and industry and is looking to cement its ambition of becoming the market leader in genome knowledge brokering.






Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst